COVID-19

The antiviral drug remdesivir is not suggested for patients admitted to hospital with the novel coronavirus (COVID-19) regardless of how severely ill

Pharmaceutical giants Pfizer and BioNTech announced today the companies would submit a request to the U.S. Food and Drug Administration (FDA) for

The U.S. Centers for Disease Control and Prevention (CDC) urged Americans in its latest guidance to avoid travel during the Thanksgiving holiday and

Last Updated: November 19, 2020

Latest Updates Include:

• FDA authorizes first at-home test; Pfizer and BioNTech vaccine 95 percent effective;

Sleep apnea could be a possible risk factor for the novel coronavirus (COVID-19), according to new research published in Sleep Medicine and

More than half of people with acute novel coronavirus (COVID-19) infection continue to have persistent fatigue 10 weeks after their initial illness,

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first at-home novel coronavirus (COVID-19)

A final efficacy analysis of the Pfizer and BioNTech novel coronavirus (COVID-19) vaccine found it is 95 percent effective in preventing infections